Gaul G, Blazek G, Deutsch E, Heeger H
Wien Klin Wochenschr. 1982 Nov 26;94(22):618-22.
A case of primary vascular pulmonary hypertension (PVPH) in a 53-year old woman (160 cm, 90 kg) is reported. She first complained of symptoms of breathlessness on exertion 2-3 months after completion of three courses of fenfluramine (Ponderax). The courses began in October 1977 and ended in May 1978. Despite persisting symptoms no relevant clinical findings were obtained. The patient was admitted to this hospital after complaining of short syncopal attacks on exertion, in November 1981. Typical signs of PVPH were now demonstrable, with a resting pulmonary pressure of 98/45 mm Hg. Clinical findings showed a similarity to those obtained in patients suffering from aminorex-induced PVPH, although fenfluramine shows some biological differences to aminorex. A causality between the development of PVPH and fenfluramine intake is probable on the basis of the patient's history, but it cannot be proven.
报告了一例53岁女性(身高160厘米,体重90千克)的原发性血管性肺动脉高压(PVPH)病例。她在完成三个疗程的芬氟拉明(Ponderax)治疗2至3个月后首次出现劳力性呼吸困难症状。疗程于1977年10月开始,1978年5月结束。尽管症状持续存在,但未获得相关临床发现。该患者于1981年11月因劳力性短暂晕厥发作前来就诊后入住本院。此时PVPH的典型体征已可显现,静息肺动脉压为98/45毫米汞柱。临床发现与服用氨基苯唑所致PVPH患者的表现相似,尽管芬氟拉明与氨基苯唑在生物学特性上存在一些差异。根据患者病史,PVPH的发生与服用芬氟拉明之间可能存在因果关系,但无法得到证实。